Genetix Biotech Asia News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Genetix biotech asia. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Genetix Biotech Asia Today - Breaking & Trending Today

Cureus | SARS-CoV-2 Mutations Responsible for Immune Evasion Leading to Breakthrough Infection

Background and objectives: India had faced a devastating second outbreak of COVID-19 infection, in which a majority of the viral sequences were found to be of the B.1.617.2 lineage (Delta-variant). While India and the world focused on vaccination, reports of vaccine-immunity evasion by the virus, termed “breakthrough cases”, emerged worldwide. Our study was focused on the primary objective to identify the mutations associated with breakthrough infections SARS-CoV-2.

Methods: In our study, we extracted the SARS-CoV-2 RNA (ribonucleic acid) from reverse transcription-polymerase chain reaction (RT-PCR) positive COVID-19 patients, and 150 random samples were sent for sequencing to the Centre for Cellular & Molecular Biology, Hyderabad. Whole genome sequences of 150 SARS-CoV-2 viral samples were analyzed thoroughly. We mostly found B.1.617 and its sub-lineages in the genomic sequencing results.

Results and interpretation: On further analysis of patient data, ....

United States , Andhra Pradesh , Uttar Pradesh , Centre For Cellular Molecular Biology , Institute Of Medical Sciences , Multidisciplinary Research Unit , Patient Department , Banaras Hindu University , Centre For Cell , Institutional Ethical Committee , Centre Of Cellular , While India , Molecular Biology , Sir Sunderlal Hospital , Out Patient Department , Medical Sciences , Thermo Scientific , Genetix Biotech Asia , Virus Surveillance Server , Ghost Change , Viral Oligomerization ,

Now, 179 COVID-19 testing kits available in India; about 40 indigenous


Now, 179 COVID-19 testing kits available in India; about 40 indigenous
In the early days of COVID-19 outbreak last year, India relied on imports from leading medical companies like Roche Diagnostic, Korea s S.D Biosensor, Siemens Healthcare, Thermofisher, Abbott Healthcare, apart from Chinese and South Korean manufacturers
PB Jayakumar | February 23, 2021 | Updated 17:43 IST
Pune s Mylab was among the first to commercialise an indigenous testing kit in March, 2020
The Drug Controller General of India (DCGI) has approved 179 COVID-19 testing kits until mid-February. These testing kits include those produced by 30-40 Indian companies.
In the early days of COVID-19 outbreak last year, India relied on imports from leading medical companies like Roche Diagnostic, Korea s S.D Biosensor, Siemens Healthcare, Thermofisher, Abbott Healthcare, apart from Chinese and South Korean manufacturers. ....

South Korea , Madhya Pradesh , South Korean , Pontika Aerotech , Helini Biomolecules , Affigenix Biosolutions , Wrig Nanosystems , Market Research , Karwa Enterprises , Drug Controller General , Roche Diagnostic , Siemens Healthcare , Abbott Healthcare , Trivitron Healthcare , Tata Medical , Medipol Pharmaceutical India , Aspen Laboratories , Bhatt Biotech India , Achira Labs , Nucleus Diagnosys , Molbio Diagnostics , Biosystems Diag , Neodx Biotech Labs , Cepheid India , Cosara Diagnostics , Genetix Biotech Asia ,

adrenoleukodystrophy treatment Market Set to Register healthy CAGR Forecast to 2027 – KSU


The 
adrenoleukodystrophy treatment Market research report thoroughly explains each and every aspect related to the Global adrenoleukodystrophy treatment Market, which facilitates the report’s reader to study and evaluate the upcoming market trend and execute the analytical data to promote the business.
adrenoleukodystrophy treatment Market Insight:
Adrenoleukodystrophy treatment market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market is growing at a substantial CAGR in the above-mentioned research forecast period. Rising prevalence of the disease, growing awareness and development of newer therapies with minimum invasive nature are the factors responsible for the growth of this market ....

United States , Hong Kong , United Kingdom , South Africa , Saudi Arabia , Asia Pacific , Jazz Pharmaceuticals Inc , Research Methodology , Orpheris Inc , Neurovia Inc , Medday Pharmaceuticals , Receptopharm Inc , Market Research , Pfizer Inc , Amgen Inc , Nutra Pharma Corporation , Contents Of This Premium Research , Market Insight , Bridge Market Research , Free Sample Copy , Key Players , Myelin Project , Viking Therapeutics , Genetix Biotech Asia , Magenta Therapeutics , Jazz Pharmaceuticals ,